<div id="readability-page-1"><p>Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,498,366 shares,  a decline of 54.4% from the December 31st total of 3,282,838 shares. Based on an average trading volume of 903,681 shares, the short-interest ratio is currently 1.7 days. Currently, 2.6% of the company's shares are sold short. Currently, 2.6% of the company's shares are sold short. Based on an average trading volume of 903,681 shares, the short-interest ratio is currently 1.7 days.</p><h2>Omada Health Trading Up 1.6%</h2><p>NASDAQ OMDA opened at $15.65 on Thursday. The business's 50-day moving average price is $16.19 and its two-hundred day moving average price is $19.87. The firm has a market capitalization of $906.29 million and a PE ratio of -62.60. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40. </p><h2>Insider Transactions at Omada Health</h2><p>In other news, CEO Sean P. Duffy sold 40,796 shares of Omada Health stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $15.95, for a total value of $650,696.20. Following the completion of the sale, the chief executive officer directly owned 126,644 shares in the company, valued at approximately $2,019,971.80. The trade was a 24.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this link. Also, President Wei-Li Shao sold 5,618 shares of the business's stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the transaction, the president directly owned 69,079 shares of the company's stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 276,893 shares of company stock worth $4,336,787. </p><h2>Hedge Funds Weigh In On Omada Health</h2><p>Institutional investors have recently made changes to their positions in the stock. TD Waterhouse Canada Inc. acquired a new stake in  Omada Health in the fourth quarter valued at approximately $32,000.  Raymond James Financial Inc. acquired a new stake in shares of  Omada Health in the 2nd quarter worth about $32,000.  Strs Ohio bought a new stake in  Omada Health during the 3rd quarter worth approximately $38,000.  Inlight Wealth Management LLC bought a new position in shares of  Omada Health in the fourth quarter valued at approximately $45,000.  Finally, Rakuten Investment Management Inc. purchased a new stake in  Omada Health in the 3rd quarter valued at $49,000. </p><h2>Analyst Upgrades and Downgrades</h2><p>OMDA has been the subject of a number of research analyst reports. Evercore ISI upped their price objective on shares of Omada Health from $27.00 to $28.00 and gave the stock an &#34;outperform&#34; rating in a research report on Friday, November 7th. Barclays decreased their target price on shares of Omada Health from $29.00 to $22.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, January 5th. Weiss Ratings  reiterated a &#34;sell (d)&#34; rating on shares of Omada Health in a research note on Thursday, January 22nd. Needham &amp; Company LLC  reissued a &#34;buy&#34; rating and set a $28.00 price objective on shares of Omada Health in a report on Thursday, January 22nd. Finally, BMO Capital Markets started coverage on Omada Health in a report on Thursday, November 13th. They issued an &#34;outperform&#34; rating and a $27.00 target price for the company. Eight analysts have rated the stock with a Buy rating, two have assigned  a Hold rating and one  has given a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $25.10.</p><p><b>View Our Latest Stock Report on OMDA</b></p><h2>About Omada Health</h2> (Get Free Report)<p>Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.  </p><p>In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Omada Health</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>Do not delete, read immediately</li><li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Omada Health Right Now?</h2><p>Before you consider Omada Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p><p>While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Omada Health, Inc. (NASDAQ:OMDA) experienced a significant decline in short interest, dropping 54.4% in January to 1,498,366 shares. The days-to-cover ratio is currently 1.7 days, with 2.6% of shares sold short. The stock opened at $15.65, with a market cap of $906.29 million. Recent insider transactions include CEO Sean P. Duffy selling 40,796 shares. Analysts have mixed ratings, with a consensus rating of "Moderate Buy" and a target price of $25.10. Omada Health focuses on digital health solutions for chronic conditions.</p>

Market Beat

SPDR S&P Health

SPDR S&P Health Equip

iShares Expanded Tech Software Sector ETF

Franklin Exponential Data ETF

Global X Cloud Computing ETF

iShares US Healthcare Providers

iShares US Digital Infrastructure and Real Estate ETF

SPDR S&P Software

Proshares Big Data Refiners ETF

Omada Health

iShares US Medical Devices

Global X Data Center & Dgtl Infrs ETF

Omada Health, Inc. (NASDAQ:OMDA) Short Interest Down 54.4% in January